More young children between the ages of 2 and 5 years are being diagnosed with bipolar disorder and receiving antipsychotic drugs compared with 10 years ago.
More young children between the ages of 2 and 5 years are being diagnosed with bipolar disorder and receiving antipsychotic drugs compared with 10 years ago. In fact, the number of children with such a diagnosis has doubled in that time, according to research published in the January 2010 issue of the Journal of the American Academy of Child and Adolescent Psychiatry.
Although it is still atypical to prescribe potent psychiatric drugs to 2-year-olds, the frequency of this occurrence is growing as well.
Data from the study, which was conducted at Columbia University from 2000 to 2007, indicated that in 2007, about 1.5% of all privately insured children between the ages of 2 and 5, or 1 in 70 children, were prescribed a psychotropic drug, which may be an antipsychotic, a mood stabilizer, a stimulant, or an antidepressant.
Stress ulcer prophylaxis does not provide prevention of gastrointestinal bleeding in neonates
December 4th 2023In a poster abstract presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting & Exhibition held in Anaheim, California, stress ulcer prophylaxis (SUP) did not appear to provide benefit for prevention of gastrointestinal bleeding and did not increase SUP-associated adverse effects.
AAP cautions against low-carbohydrate diets for children at risk for diabetes
December 1st 2023According to the American Academy of Pediatrics (AAP), it is recommended that 45% to 65% of total daily calories come from carbohydrates, though very low-carbohydrate diets allow for 20 to 50 grams per day.